Abstract

e16082Background: This study was designed to explore the plasma cell free DNA (cfDNA) mutation profile in the patients with esophageal squamous cell carcinoma (ESCC) response and non-response to ne...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Fc fragment of immunoglobulin G receptor IIa (FCGR2A) as a new potential prognostic biomarker of esophageal squamous cell carcinoma.
Wengeng Zhang ... Nan Li
Chinese medical journal | VOL. 135
Wengeng Zhang, et. al.Wengeng Zhang ... Nan Li
05 Nov 2021
Effects of neutropenia and histological responses in esophageal squamous cell carcinoma with neo-adjuvant chemotherapy.
Hidekazu Hiramoto ... Kazuma Okamoto
International journal of clinical oncology | VOL. 21
Hidekazu Hiramoto, et. al.Hidekazu Hiramoto ... Kazuma Okamoto
21 Jul 2015
Transcriptional factor regulation network and competitive endogenous RNA (ceRNA) network determining response of esophageal squamous cell carcinomas to neoadjuvant chemoradiotherapy.
Mingrui Shao ... Wenya Li
PeerJ | VOL. 7
Mingrui Shao, et. al.Mingrui Shao ... Wenya Li
29 Mar 2019
Predictive value of intravoxel incoherent motion imaging for pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma
...
Chinese Journal of Digestive Surgery | VOL. 18
, et. al. ...
20 Jun 2019
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori ... Fabio Ciceri
Journal of Clinical Oncology | VOL. -
Cristina Astrid Tentori, et. al.Cristina Astrid Tentori ... Fabio Ciceri
09 May 2024
Addressing Disability in Cancer Survivors
Rachelle Brick ... Emily S Tonorezos
Journal of Clinical Oncology | VOL. -
Rachelle Brick, et. al.Rachelle Brick ... Emily S Tonorezos
09 May 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker ... Niall C Tebbutt
Journal of Clinical Oncology | VOL. -
Susanna Hegewisch-Becker, et. al.Susanna Hegewisch-Becker ... Niall C Tebbutt
09 May 2024
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation.
Yuankai Shi ... Zhengbo Song
Journal of Clinical Oncology | VOL. 42
Yuankai Shi, et. al.Yuankai Shi ... Zhengbo Song
30 Apr 2024
View more papers